Five-Year Survival for End-Stage Renal Disease Patients in the United States, Europe, and Japan, 1982 to 1987

Held, Philip J.; Brunner, Felix; Odaka, Michio; Garcia, Jose R.; Port, Friedrich K.; Gaylin, Daniel S.

doi:10.1016/s0272-6386(12)70363-3

Cited by 284 publications

(152 citation statements)

References 3 publications

Supporting

Mentioning

142

Contrasting

Unclassified

Order By: Relevance

“…Third, all enrolled patients in the study were Japanese. A report showed that 5-year survival rates in overall patients on HD were 54% in Japan, 48% in Europe, and 40% in the United States, respectively (34). These differences should be considered to interrupt the results.…”

Section: Limitationsmentioning

confidence: 99%

Prognostic Value of Reduced Left Ventricular Ejection Fraction at Start of Hemodialysis Therapy on Cardiovascular and All-Cause Mortality in End-Stage Renal Disease Patients

Yamada

Ishii²,

Takahashi

et al. 2010

Clinical Journal of the American Society of Nephrology

View full text Add to dashboard Cite

Background and objectives: Cardiac failure is directly affected by left ventricular (LV) dysfunction, and particularly LV systolic dysfunction is strongly associated with survival in ESRD patients. The aim of this study was to determine the prognostic value of reduced LV ejection fraction (LVEF) measured at the time of initiation of hemodialysis (HD) in incident HD patients.Design, setting, participants, & measurements: 1254 consecutive ESRD patients who electively started HD therapy were screened by echocardiography within 1 month after its inception. They were divided into five groups according to LVEF levels with a decrease of 0.1 each and were followed up for up to 7 years. Survival was examined with the Kaplan-Meier method and compared using the log-rank test.Results: Among the 1254 patients, LVEF levels >0. Conclusions: Reduced LVEF on starting HD therapy could stratify risk of cardiovascular and all-cause mortality in ESRD patients. Screening by echocardiography at start of HD therapy might be recommended to predict prognosis in patients with ESRD.

show abstract

Section: Limitationsmentioning

confidence: 99%

Prognostic Value of Reduced Left Ventricular Ejection Fraction at Start of Hemodialysis Therapy on Cardiovascular and All-Cause Mortality in End-Stage Renal Disease Patients

Yamada

Ishii²,

Takahashi

et al. 2010

Clinical Journal of the American Society of Nephrology

View full text Add to dashboard Cite

show abstract

“…The findings of Held et al (1) were considered controversial by many because of the concern that they might reflect or imply poorer care of dialysis patients in the United States. In this section, we consider alternative explanations (e.g., various sources of bias) that may in part explain the findings, and we explore the possible role of differences in dialysis treatment delivery that may account for some of the survival differences.…”

Section: Potential Explanations For Regional Differences In Survivalmentioning

confidence: 99%

International Hemodialysis Patient Outcomes Comparisons Revisited

Robinson

Port²

2009

Clinical Journal of the American Society of Nephrology

Self Cite

View full text Add to dashboard Cite

“…Differences in ESRD patient survival for Europe, Japan, and the USA have been found to be based largely on registry data, after adjusting for age and diabetes [89]. Subsequent study of hemodialysis patients, based on the DOPPS, confirmed these significant differences, albeit of a lesser magnitude, when allowing for greater adjustments for case mix and achieving better death ascertainment [90].…”

Section: Survival After Initiation Of Rrtmentioning

confidence: 99%